SCHEMBL113754

SCHEMBL113754

O=C(CN1C(=O)[N]c2ccccc21)N1CCN(c2ccc(F)cc2-c2cnc(N3CCC(O)CC3)nc2)CC1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CXCR3 P49682 1/20 0.47
KCNH2 Q12809 1/20 0.47
KDM4E B2RXH2 4/20 0.39
HSD17B10 Q99714 2/20 0.39
CASP1 P29466 1/20 0.39
CASP7 P55210 1/20 0.39
GRM5 P41594 2/20 0.38
LMNA P02545 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
RAB9A P51151 1/20 0.37
MAPT P10636 3/20 0.37
AOC3 Q16853 2/20 0.37
TP53 P04637 1/20 0.36
ALDH1A1 P00352 3/20 0.36
HPGD P15428 2/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
GAA P10253 1/20 0.36
HTT P42858 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL113905 0.89 KDM4E (0.41) KDM4EHSD17B10CASP1CASP7MAPT
SCHEMBL23921279 0.81 CXCR3 (0.47) CXCR3KCNH2KDM4EHSD17B10GRM5
SCHEMBL161709 0.81 CXCR3 (0.48) CXCR3KCNH2GRM5
SCHEMBL114794 0.80 CXCR3 (0.45) CXCR3KCNH2KDM4EGRM5ALDH1A1
SCHEMBL167757 0.79 CXCR3 (0.73) CXCR3KCNH2KDM4EGRM5MAPT
SCHEMBL3726521 0.78 CXCR3 (0.51) CXCR3KCNH2GRM5GAA
SCHEMBL167336 0.78 CXCR3 (0.55) CXCR3KCNH2GRM5TP53
SCHEMBL3728849 0.77 CXCR3 (0.42) CXCR3KCNH2KDM4EGRM5LMNA
SCHEMBL167110 0.77 GRIN2B (0.45) CXCR3KCNH2GRM5MAPT
SCHEMBL163154 0.77 GRM5 (0.43) CXCR3KCNH2KDM4EGRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2424840-A1 CXCR3 RECEPTOR ANTAGONISTS Boehringer Ingelheim International GmbH (DE) 2012-03-07 EP disclosed
WO-2010126811-A1 CXCR3 RECEPTOR ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-11-04 WO disclosed